project id: TCGA-ESCA; case submitter id: TCGA-R6-A6DN; source center: 23; state: released; a260 a280 ratio: 1.38; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.57; rna integrity number: 8.4; age at index: 58; days to birth: -21259; days to death: 243; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Dead; year of birth: 1953; year of death: 2011; age at diagnosis: 21259; ajcc clinical m: M1; ajcc clinical n: NX; ajcc clinical stage: Stage IV; ajcc clinical t: TX; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C15.4; last known disease status: not reported; morphology: 8140/3; primary diagnosis: Adenocarcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Middle third of esophagus; synchronous malignancy: No; tissue or organ of origin: Middle third of esophagus; tumor grade: Not Reported; year of diagnosis: 2011; alcohol history: Yes; cigarettes per day: 0.4383561643835616; pack years smoked: 8.0; is ffpe: false; weight: 5.0; composition: Not Reported; days to collection: 678; days to sample procurement: 0; initial weight: 5.0; sample id: e987d5a1-d089-439f-8e9e-4eaf71cf752a; sample submitter id: TCGA-R6-A6DN-01B; portion id: c46d2194-b312-42c4-bd3a-8ad570ba7824; portion submitter id: TCGA-R6-A6DN-01B-11; slide id: f0f21659-8f9e-415a-a0a8-8eb27ff6d312; slide submitter id: TCGA-R6-A6DN-01Z-00-DX1; percent lymphocyte infiltration: 40.0; percent monocyte infiltration: 20.0; percent necrosis: 0.0; percent neutrophil infiltration: 20.0; percent normal cells: 0.0; percent stromal cells: 20.0; percent tumor cells: 80.0; percent tumor nuclei: 80.0; section location: TOP;